PRCT vs INMD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 01, 2026
PRCT
57.4
AI Score
VS
PRCT Wins
INMD
49.9
AI Score
Investment Advisor Scores
INMD
50score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | PRCT | INMD | Winner |
|---|---|---|---|
| Revenue | 308.05M | 370.50M | INMD |
| Net Income | -95,572 | 93.83M | INMD |
| Gross Margin | 63.7% | 78.5% | INMD |
| Net Margin | -0.0% | 25.3% | INMD |
| Operating Income | -103.86M | 85.39M | INMD |
| ROE | -0.0% | 13.7% | INMD |
| ROA | -0.0% | 12.2% | INMD |
| Total Assets | 508.08M | 766.43M | INMD |
| Cash | 286.50M | 302.54M | INMD |
| Current Ratio | 6.85 | 9.88 | INMD |
| Free Cash Flow | -58.34M | 84.28M | INMD |
Relative Price Performance (Last 90 Days)
PRCT 1M: -18.6%
· 3M: -19.1%
INMD 1M: -6.5%
· 3M: -5.1%
Current Technical Phase
PRCT
MarkdownSell / avoid
Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 35
INMD
MarkdownSell / avoid
Price below a falling SMA50 (slope -1.2%), weak momentum, RSI 28
Fundamentals Snapshot
| Metric | PRCT | INMD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -14.8 | 10.2 |
| Trailing P/E | — | 11.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.6% | 0.8% |
| Operating Margin | -0.3% | 0.1% |
| EPS | -1.95 | 1.21 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, PRCT is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.